celastrol has been researched along with Pre-Eclampsia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, Y; Wang, D; Xiao, S; Zhang, M | 1 |
| He, Z; Wang, D; Xiao, S; Zhang, M | 1 |
1 trial(s) available for celastrol and Pre-Eclampsia
| Article | Year |
|---|---|
Celastrol synergizes with oral nifedipine to attenuate hypertension in preeclampsia: a randomized, placebo-controlled, and double blinded trial.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hypertension; Nifedipine; Pentacyclic Triterpenes; Pre-Eclampsia; Pregnancy; Time Factors; Treatment Outcome; Triterpenes; Young Adult | 2017 |
1 other study(ies) available for celastrol and Pre-Eclampsia
| Article | Year |
|---|---|
Celastrol attenuates symptoms of preeclampsia in rats by inhibiting matrix metalloproteinase-9.
Topics: Animals; Female; Intracellular Signaling Peptides and Proteins; Kidney; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Membrane Proteins; NG-Nitroarginine Methyl Ester; Pentacyclic Triterpenes; Placenta Growth Factor; Pre-Eclampsia; Pregnancy; Rats, Sprague-Dawley; RNA, Messenger; Triterpenes; Vascular Endothelial Growth Factor Receptor-1 | 2018 |